NDC49884-0763-78 (Fentanyl Transdermal System) by Par Pharmaceutical Inc - Request a Quote Now

Part No. : NDC49884-0763-78 Alternate P/N : NDC49884076378 Manufacturer : Par Pharmaceutical Inc
CAGE Code : 0VZ14 Item Name : Fentanyl Transdermal System NSN : 6505-01-656-4667

You can send a request for quote for p/n NDC49884-0763-78 to ASAP Semiconductor using justpartsunlimited.com. This part is manufactured by Par Pharmaceutical Inc (CAGE Code 0VZ14). The description of it is Fentanyl Transdermal System. The national stock number associated with this part is NSN 6505016564667. This part belongs to FSC  part family. An associate from ASAP Semiconductor will respond within 15 minutes to your query. It is our pleasure to help you with NDC49884-0763-78 part requirements.

Required fields compulsory *

Contact Information

Note: We will not share your information to any third parties.

  * By clicking this box, I acknowledge that I have read and accept the ASAP Semiconductor Terms & Conditions and agree that all quotes and purchase orders are exclusively subject to the ASAP Semiconductor Terms and Conditions.

  • I consent to receive email communications from ASAP Semiconductor and can unsubscribe at any time.
  • ASAP Semiconductor is a wholly independent aftermarket parts distributor.
  • This website is intended for quotations based on part numbers only. Please DO NOT submit drawings, technical data, or other specifications through this portal.

NSN Information for Part Number NDC49884-0763-78 with NSN 6505-01-656-4667, 6505016564667

NSNFSCNIINCLSHazmatDEMILCancelled NSN
6505-01-656-4667

Item Description:

Fentanyl Transdermal System

6505016564667MP
CIICHCCESDPMICCriticalityENAC
R A0
Part NumberISCRNVCRNCCHCCMSDSSADC
Ndc49884-0763-78523

Characteristics Data of NSN 6505-01-656-4667, 6505016564667

MRCCriteriaCharacteristic
FEATSpecial FeaturesROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE
CSLZUsual Dose75 MCG/HR
CBBLFeatures ProvidedINDIVIDUALLY SEALED
CRYCControlled Substance ClassificationSCHEDULE II
CXCYPart Name Assigned By Controlling AgencyDURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S
MRCDecoded RequirementClear Text Reply
ASAP Semiconductor's Certifications and Memberships